Journal
JOURNAL OF IMMUNOLOGY
Volume 181, Issue 9, Pages 6574-6583Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.9.6574
Keywords
-
Categories
Funding
- Royal Netherlands Academy of Arts and Sciences
- Netherlands Organization for Scientific Research [NWO 814.02.012]
- Landsteiner Foundation for Blood Transfusion Research [LSBR 0310]
- Medical Faculty of the University of Leipzig
Ask authors/readers for more resources
The heptahelical receptor CD97 is a defining member of the EGF-TM7 family of adhesion class receptors. In both humans and mice, CD97 isoforms are expressed with variable numbers of tandemly arranged N-terminal epidermal growth factor-like domains that facilitate interactions with distinct cellular ligands. Results from treatment of mice with mAbs in various disease models have suggested a role for CD97 in leukocyte trafficking. Here, we aimed to thoroughly characterize the expression profile of CD97, and delineate its biological function. To this end, we applied a novel polyclonal Ab, which is the first antiserum suitable for immunohistochemistry, and combined this analysis with the study of Cd97-lacZ knock-in mice. We show that similar to the situation in humans, hematopoietic, epithelial, endothelial, muscle, and fat cells expressed CD97. Despite this broad expression pattern, the Cd97(-/-) mouse that we created had no overt phenotype, except for a mild granulocytosis. Furthermore, granulocyte accumulation at sites of inflammation was normal in the absence of CD97. Interestingly, application of CD97 mAbs blocked granulocyte trafficking after thioglycollate-induced peritonitis in wild-type but not in knock-out mice. Hence, we conclude that CD97 mAbs actively induce an inhibitory effect that disturbs normal granulocyte trafficking, which is not perturbed by the absence of the molecule. The Journal of Immunology, 2008, 181: 6574-6583.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available